Many international destinations are reporting increased numbers of cases of measles. Country List : Afghanistan, Angola, Benin, Cameroon, Central African Republic, Chad, Côte d'Ivoire (Ivory Coast), Democratic Republic of the Congo, Djibouti, Ethiopia, Gabon, India, Indonesia, Liberia, Niger, Nigeria, Pakistan, Republic of the Congo , Senegal, Somalia, Republic of South Sudan, Sudan, Tajikistan, Togo, Yemen, Zambia, Nepal, Kyrgyzstan, Armenia, Mauritania, Lebanon, Equatorial Guinea, Syria, Ghana, Kazakhstan, Burkina Faso, Turkey, Qatar, United Arab Emirates, Libya, Burundi, Romania, Malaysia, Russia, Azerbaijan, Sri Lanka, Uzbekistan, Philippines, Timor-Leste (East Timor)

Some international destinations have circulating poliovirus. Before any international travel, make sure you are up to date on your polio vaccines. Country List : Afghanistan, Algeria, Benin, Cameroon, Central African Republic, Chad, Côte d'Ivoire (Ivory Coast), Democratic Republic of the Congo, Madagascar, Malawi, Mozambique, Niger, Nigeria, Pakistan, Somalia, Yemen, Indonesia, Sudan, Mali, Botswana, Zambia, Republic of the Congo , Burundi, Burkina Faso, Kenya, Tanzania, including Zanzibar, Guinea, Mauritania, Egypt, Zimbabwe, Angola, Liberia, Senegal, Sierra Leone

There are outbreaks of Oropouche fever in parts of Brazil, Bolivia, and Peru. Travelers to affected areas should take steps to avoid bug bites. Country List : Brazil, Bolivia, Peru

There are confirmed and suspect cases of diphtheria in several regions in Guinea. Vaccination against diphtheria is essential to protect against disease. If you are traveling to an affected area, you should be up to date with your diphtheria vaccines.

Dengue is a risk in many parts of Asia and the Pacific Islands. Some countries are reporting increased numbers of cases of the disease. Travelers to Asia and the Pacific Islands can protect themselves by preventing mosquito bites. Country List : Sri Lanka, Malaysia, Cambodia, Indonesia, Laos, Singapore

Malaria is a major cause of illness worldwide. In a phase 2 trial in Mali, one subcutaneous dose of L9LS, a monoclonal antibody targeting Plasmodium falciparum, reduced the incidence of clinical malaria among children.

We in the global malaria community are at a critical juncture in our journey toward malaria eradication. Decades of experience in deploying our existing interventions have made it clear that there is no single “silver bullet.” Rather, driving down morbidity and mortality requires that we use combinations of interventions across...

Of 10 patients with relapsed or refractory hematologic cancers who received sequential CAR T-cell infusion followed by allogeneic stem-cell transplantation without GVHD prophylaxis, 6 were alive and disease-free at last follow-up.